NSABP-B-55/BIG6-13

Breast
Breast - Male

IU Health Ball Memorial Hospital

• IU Health Ball Memorial Hospital

• Eskenazi Hospital
• Indiana University Hospital / IU Simon Cancer Center
• Spring Mill Medical Center

• Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
  Tutt ANJ;Garber JE;Kaufman B;Viale G;Fumagalli D;Rastogi P;Gelber RD;de Azambuja E;Fielding A;Balmaña J;Domchek SM;Gelmon KA;Hollingsworth SJ;Korde LA;Linderholm B;Bandos H;Senkus E;Suga JM;Shao Z;Pippas AW;Nowecki Z;Huzarski T;Ganz PA;Lucas PC;Baker N;Loibl S;McConnell R;Piccart M;Schmutzler R;Steger GG;Costantino JP;Arahmani A;Wolmark N;McFadden E;Karantza V;Lakhani SR;Yothers G;Campbell C;Geyer CE; ;
• Update on Pregnancy Following Breast Cancer Diagnosis and Treatment
  Perachino M;Poggio F;Arecco L;Blondeaux E;Spinaci S;Marrocco C;Levaggi A;Lambertini M;
• Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
  Yamauchi H;Toi M;Takayama S;Nakamura S;Takano T;Cui K;Campbell C;De Vos L;Geyer C;Tutt A;
• Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
  Ganz PA;Bandos H;Španić T;Friedman S;Müller V;Kuemmel S;Delaloge S;Brain E;Toi M;Yamauchi H;de Dueñas EM;Armstrong A;Im SA;Song CG;Zheng H;Sarosiek T;Sharma P;Geng C;Fu P;Rhiem K;Frauchiger-Heuer H;Wimberger P;t'Kint de Roodenbeke D;Liao N;Goodwin A;Chakiba-Brugère C;Friedlander M;Lee KS;Giacchetti S;Takano T;Henao-Carrasco F;Virani S;Valdes-Albini F;Domchek SM;Bane C;McCarron EC;Mita M;Rossi G;Rastogi P;Fielding A;Gelber RD;Scheepers ED;Cameron D;Garber J;Geyer CE;Tutt ANJ;